Literature DB >> 8893036

Interspecies scaling: predicting clearance of drugs in humans. Three different approaches.

I Mahmood1, J D Balian.   

Abstract

1. The interspecies scaling approach to predict clearance in humans from animal data was tested for a wide variety of drugs. 2. Three different methods were utilized to generate plots to scale-up the clearance values: (i) method I, clearance versus body weight (simple allometric equation); (ii) method II, product of clearance and maximum life-span potential; (iii) method III, product of clearance and brain weight versus body weight. 3. The circumstances under which the three methods can be applied to predict clearance in humans were evaluated. 4. If the exponent lies between 0.55 to 0.7 then method I predicts clearance reasonably well. 5. If the exponent lies between 0.71 to 1.0 clearance can be predicted reasonably well by method II. 6. If the exponent is > 1.0 clearance can be predicted using method III.

Entities:  

Mesh:

Year:  1996        PMID: 8893036     DOI: 10.3109/00498259609052491

Source DB:  PubMed          Journal:  Xenobiotica        ISSN: 0049-8254            Impact factor:   1.908


  44 in total

1.  Allometric scaling of xenobiotic clearance: uncertainty versus universality.

Authors:  T M Hu; W L Hayton
Journal:  AAPS PharmSci       Date:  2001

Review 2.  Prediction of hepatic metabolic clearance based on interspecies allometric scaling techniques and in vitro-in vivo correlations.

Authors:  T Lavé; P Coassolo; B Reigner
Journal:  Clin Pharmacokinet       Date:  1999-03       Impact factor: 6.447

3.  Across-Species Scaling of Monoclonal Antibody Pharmacokinetics Using a Minimal PBPK Model.

Authors:  Jie Zhao; Yanguang Cao; William J Jusko
Journal:  Pharm Res       Date:  2015-05-05       Impact factor: 4.200

Review 4.  The pharmacokinetic principles behind scaling from preclinical results to phase I protocols.

Authors:  I Mahmood; J D Balian
Journal:  Clin Pharmacokinet       Date:  1999-01       Impact factor: 6.447

5.  Allometric pharmacokinetic scaling: towards the prediction of human oral pharmacokinetics.

Authors:  M R Feng; X Lou; R R Brown; A Hutchaleelaha
Journal:  Pharm Res       Date:  2000-04       Impact factor: 4.200

6.  Engineering challenges for instrumenting and controlling integrated organ-on-chip systems.

Authors:  John P Wikswo; Frank E Block; David E Cliffel; Cody R Goodwin; Christina C Marasco; Dmitry A Markov; David L McLean; John A McLean; Jennifer R McKenzie; Ronald S Reiserer; Philip C Samson; David K Schaffer; Kevin T Seale; Stacy D Sherrod
Journal:  IEEE Trans Biomed Eng       Date:  2013-02-01       Impact factor: 4.538

7.  Interspecies allometric scaling of antimalarial drugs and potential application to pediatric dosing.

Authors:  S M D K Ganga Senarathna; Kevin T Batty
Journal:  Antimicrob Agents Chemother       Date:  2014-08-04       Impact factor: 5.191

8.  Preclinical pharmacokinetics and interspecies scaling of ragaglitazar, a novel biliary excreted PPAR dual activator.

Authors:  Venkata V Pavankuamr; C A Vinu; Ramesh Mullangi; Nuggehally R Srinivas
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2007 Jan-Mar       Impact factor: 2.441

9.  Interspecies modeling and prediction of human exenatide pharmacokinetics.

Authors:  Ting Chen; Donald E Mager; Leonid Kagan
Journal:  Pharm Res       Date:  2012-11-15       Impact factor: 4.200

10.  Discovery of IWP-051, a Novel Orally Bioavailable sGC Stimulator with Once-Daily Dosing Potential in Humans.

Authors:  Takashi Nakai; Nicholas R Perl; Timothy C Barden; Andrew Carvalho; Angelika Fretzen; Peter Germano; G-Yoon J Im; Hong Jin; Charles Kim; Thomas W-H Lee; Kimberly Long; Joel Moore; Jason M Rohde; Renee Sarno; Chrissie Segal; Erik O Solberg; Jenny Tobin; Daniel P Zimmer; Mark G Currie
Journal:  ACS Med Chem Lett       Date:  2016-02-24       Impact factor: 4.345

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.